Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis

2011 ◽  
Vol 14 (2) ◽  
pp. 207-216 ◽  
Author(s):  
Anne-Laure Guillermin ◽  
Yevgeniy Samyshkin ◽  
Donna Wright ◽  
Tini Nguyen ◽  
Julie Villeneuve
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Detemir ◽  
Cost Minimization ◽  
Meta Analysis ◽  
Cost Minimization Analysis ◽  
Lifetime Costs ◽  
Diabetes Patients

Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes

2010 ◽  
Vol 118 (05) ◽  
pp. 320-324 ◽  
Author(s):  
A. Tone ◽  
I. Iseda ◽  
C. Higuchi ◽  
K. Tsukamoto ◽  
A. Katayama ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Detemir ◽  
Glycemic Variability

Body Composition and Epicardial Fat in Type 2 Diabetes Patients Following Insulin Detemir Versus Insulin Glargine Initiation

2015 ◽  
Vol 48 (01) ◽  
pp. 42-47 ◽  
Author(s):  
B. Elisha ◽  
M. Azar ◽  
N. Taleb ◽  
S. Bernard ◽  
G. Iacobellis ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Composition ◽  
Insulin Glargine ◽  
Insulin Detemir ◽  
Epicardial Fat ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document